Page last updated: 2024-11-04

3,4,4a,10b-tetrahydro-4-propyl-2h,5h-(1)benzopyrano(4,3-b)-1,4-oxazin-9-ol and Anochlesia

3,4,4a,10b-tetrahydro-4-propyl-2h,5h-(1)benzopyrano(4,3-b)-1,4-oxazin-9-ol has been researched along with Anochlesia in 2 studies

3,4,4a,10b-tetrahydro-4-propyl-2H,5H-(1)benzopyrano(4,3-b)-1,4-oxazin-9-ol: RN given refers to (+/-)-isomer; RN, RRs & structure given in first source

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Audinot, V1
Newman-Tancredi, A1
Gobert, A1
Rivet, JM1
Brocco, M1
Lejeune, F1
Gluck, L1
Desposte, I1
Bervoets, K1
Dekeyne, A1
Millan, MJ1
Boulay, D1
Depoortere, R1
Perrault, G1
Borrelli, E1
Sanger, DJ1

Other Studies

2 other studies available for 3,4,4a,10b-tetrahydro-4-propyl-2h,5h-(1)benzopyrano(4,3-b)-1,4-oxazin-9-ol and Anochlesia

ArticleYear
A comparative in vitro and in vivo pharmacological characterization of the novel dopamine D3 receptor antagonists (+)-S 14297, nafadotride, GR 103,691 and U 99194.
    The Journal of pharmacology and experimental therapeutics, 1998, Volume: 287, Issue:1

    Topics: 2-Naphthylamine; 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Benzopyrans; Binding, Competitive;

1998
Dopamine D2 receptor knock-out mice are insensitive to the hypolocomotor and hypothermic effects of dopamine D2/D3 receptor agonists.
    Neuropharmacology, 1999, Volume: 38, Issue:9

    Topics: Animals; Benzopyrans; Body Temperature; Catalepsy; Dopamine Agonists; Fever; Mice; Mice, Inbred C57B

1999